Developments include low-dose atropine eye drops and LASIK procedures. The global myopia and presbyopia treatment market is ...

The global market for myopia and presbyopia treatment has witnessed significant momentum, driven by increasing cases of vision impairment and the growing prevalence of age-related eye conditions. With ...

DelveInsight's“Presbyopia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Presbyopia, historical and forecasted epidemiology as well as the ...

The company sees AGN-190584 as being a first-line treatment for people newly-diagnosed with mild-to-moderate presbyopia, or as an adjunct to reading glasses for people who want more flexibility in ...

Patients with presbyopia experienced improvements in near vision after treatment with Brimochol PF in a second phase 3 pivotal trial, according to a press release from Tenpoint Therapeutics.

The FDA has approved the first and so far only pharmacological treatment for presbyopia, a sight condition that typically starts in middle age and involves difficulty in focusing on near objects ...

Mumbai-based Entod Pharmaceuticals has developed PresVu Eye Drops for presbyopia treatment, a condition which affects between 1.09 billion and 1.80 billion people worldwide. Presbyopia occurs ...

Tenpoint Therapeutics, Inc., a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye, today reported positive topline results from BRIO-II, ...